Missing/wrong data?
Log in to edit
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
scientific article published on 01 June 2020
Author/s
author: Paolo Antonio Ascierto, Piotr Rutkowski, Andrzej Mackiewicz, Dirk Schadendorf, Inge Marie Svane
Work details
Publication date
June 1, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.